EUPATI E-learning Platform - Your expectations
The European Patients’ Academy on Therapeutic Innovation (EUPATI) is a public-private partnership providing education and training in medicines research and development and how patients can be involved as partners. Our education is for patients, patient representatives and other stakeholders in Europe and across the world.
Patient engagement is gaining more and more attention, and more patients and patient representatives want to be trained and empowered with reliable information on medicines research and development to engage meaningfully with other stakeholders. EUPATI offers education and updated reliable information about medicine’s research and development and related content (clinical trials, ethics in research, safety of medicines, etc).
The future EUPATI learning platform will provide free access to all educational resources as well as an opportunity to obtain certifications for a fee on three levels. The lessons will be grouped into modules that do not rely on the completion of other modules to be taken.
- Online certifications on 30 individual lessons
- Online certifications on 6 modules that each cover several lessons
- Certification as EUPATI Fellow which requires online certifications on all modules and 2 face-to-face trainings of 3 days each.
As part of the future e-learning platform, we would like to hear from you about your expectations, ideas, and suggestions. This survey will be used to define the learners’ interests, motivations, learning pathways and other essential aspects of the future activity of EUPATI. It should take you less than 15 minutes to complete this survey.
The above initiative falls under an EIT Health funded project called EUPATI Reload with European Patients' Forum, Bayer and Biopeople/University of Copenhagen as partners.
Should you have any questions, brilliant ideas or suggestions, please drop us a line at
! Thank you for your collaboration,
EUPATI Reload and EUPATI Team
Page 1 of 5
Never submit passwords through Google Forms.
This content is neither created nor endorsed by Google.
Terms of Service